z-logo
Premium
Murine androgen‐independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP
Author(s) -
Uchida Kohsuke,
Masumori Naoya,
Takahashi Atsushi,
Itoh Naoki,
Kato Kazunori,
Matusik Robert J.,
Tsukamoto Taiji
Publication year - 2005
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.20369
Subject(s) - lncap , gelsolin , metastasis , cancer research , prostate cancer , cancer cell , biology , cell culture , medicine , cancer , actin , microbiology and biotechnology , genetics
BACKGROUND Although neuroendocrine (NE) cells in prostate cancer have been speculated to accelerate the growth and progression of surrounding cancer cells, the evidence is as yet inconclusive. We investigated the effect of an NE allograft (NE‐10) and its cell line, NE‐CS, which were established from the prostate of the LPB‐Tag 12T‐10 transgenic mouse, on human prostate cancer cell line LNCaP. METHODS The proliferation and pulmonary metastasis of LNCaP xenografts in athymic mice with and without NE‐10 allografts were evaluated. Boyden chamber assay and microarray analysis were performed to investigate changes in invasion/migration and mRNA of LNCaP cells under the influence of the NE cells, respectively. RESULTS NE‐10 did not influence the proliferation of LNCaP. The pulmonary metastasis of LNCaP with NE‐10 significantly increased compared to mice without it. The NE‐CS cells accelerated the in vitro invasion/migration of adenocarcinoma cells. Increased expression of mRNA of gelsolin was observed in LNCaP cells incubated with the supernatant of NE‐CS cells. CONCLUSIONS The NE‐10 allograft promotes pulmonary metastasis of subcutaneously inoculated LNCaP cells by facilitating cell invasion. Secretions from NE cells upregulate the expression of gelsolin, which is an actin‐binding protein, resulting in acceleration of the migration of LNCaP cells. © 2005 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here